MedTrace Logo

Stress & Social Cognition in BPD (part 2)

NCT05310253 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2025-03-06

No results posted yet for this study

Summary

The investigators will examine how a combination of pharmacological mineralocorticoid receptor (MR) stimulation and psychosocial stress will influence prosocial behavior in patients with Borderline Personality Disorder (BPD) compared to healthy controls (HC).

Conditions

  • Borderline Personality Disorder

Interventions

DRUG

Fludrocortisone

pill of fludrocortisone

DRUG

Placebo

placebo pill

BEHAVIORAL

Trier Social Stress Test (TSST)

psychosocial stress induction

BEHAVIORAL

Placebo Trier Social Stress Test (P-TSST)

control condition

Sponsors & Collaborators

  • Charite University, Berlin, Germany

    lead OTHER

Study Design

Allocation
NA
Purpose
OTHER
Masking
TRIPLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2025-03-01
Completion
2025-03-01

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05310253 on ClinicalTrials.gov